Navigation Links
Ulthera Launches New Aesthetic Clinical Indication - Treatment of the Decolletage - in Asia
Date:7/3/2012

MESA, Ariz., July 3, 2012 /PRNewswire/ -- Ulthera, Inc. – a global, growth-stage medical device company pioneering aesthetic and medical applications using its therapeutic ultrasound platform technology – today announced the commercial availability of the Ulthera System in select Asian countries to non-invasively treat the skin on the chest area – also known as the decolletage or decollete.

The Ulthera System – which combines time-honored ultrasound imaging with focused ultrasound therapy in a procedure known as Ultherapy – has been used in many Asian countries to treat the face and neck since 2008. The new decolletage indication will utilize the System's same technology to encourage the natural formation of collagen and elastin on the chest – just as with the face and neck – giving it the ability to lift tissue. For the decolletage, this lifting effect can result in a gradual reduction of chest wrinkles over three months, with continued improvement possible for up to six months post-procedure.

"The global demand for safe and effective non-invasive procedures is rapidly growing. This is why Ulthera has made significant investments in clinical development to qualify our ultrasound platform technology for a host of medical and off-face aesthetic indications," said Matthew Likens, president and CEO of Ulthera. "Launching the decolletage treatment in Asia is just the tip of the iceberg. We anticipate an exciting second half of 2012 with even more international indications on the horizon as well as additional countries where System clearance is anticipated."

Starting July 3, 2012, Ulthera will be initiating a multi-country tour in Asia to introduce the new clinical indication to practitioners. For more information on the tour, contact Candice Wong at c.wong@ulthera.com or +852-9650-1505.

The Ulthera System is cleared by the U.S. FDA for use in a non-invasive treatment of the face to lift the eyebrow to achieve a desired aesthetic effect. The new clinical indication to treat the decolletage will not be commercially available in all Asian countries, including those that do not currently offer Ultherapy as well as Singapore and Hong Kong where the System is only cleared to treat the face.  

About Ulthera
Ulthera, Inc. is a global, growth-stage medical device company pioneering aesthetic and medical applications using its therapeutic ultrasound platform technology. The Ulthera® System is the first and only energy-based device to receive FDA clearance for a non-invasive aesthetic lift indication. The first application for Ultherapy® – the procedure enabled by the System – is a non-invasive treatment of the face to achieve a brow lift. Founded in 2004 and based in Mesa, Ariz., Ulthera is a privately held company backed by top tier venture capital firms, New Enterprise Associates and Apposite Capital. For more information, visit www.ultherapy.com.

 


'/>"/>
SOURCE Ulthera, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Bulgaria Launches Development of National Hepatitis Plan
2. Fidelitas Launches Unique Methadone Documentation and Dispensing System in Canada
3. Mylan Launches Thiamine Hydrochloride Injection
4. PeriGen, Inc. Launches Consumer Safety Campaign to Raise Awareness of Dangerous Birth Complication
5. Varian X-Ray Products Business Launches On-Line Product Finder for Customers
6. Konica Minolta Sensing America Launches Spanish Website in Support of Growing Demand In Latin American Countries
7. The Michael J. Fox Foundation Launches The $14 Million-Edmond J. Safra Core Programs for PD Research
8. Lifescript Launches New Online Asthma Health Center
9. AUA Foundation Launches Campaign to Address Stigma of Overactive Bladder
10. Smith & Nephew launches two plating systems for foot and ankle surgeons at AOFAS annual meeting in San Diego
11. Lilly Diabetes Launches 8th Annual Diabetes Summer Camp Tour With Olympian Kris Freeman
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... Oct. 12, 2017 West Pharmaceutical Services, ... solutions for injectable drug administration, today announced that it ... opens on Thursday, October 26, 2017, and will follow ... business expectations at 9:00 a.m. Eastern Time. To participate ... (International). The conference ID is 94093362. ...
(Date:10/10/2017)... 10, 2017  NDS received FDA 510(k) clearance in May 2017 ... display stand specifically designed for endoscopy environments. An innovative secondary monitor ... clinical solution to support the improvement of patient outcomes, procedural efficiency, ... ... ...
(Date:10/4/2017)... the Centers for Disease Control and Prevention (CDC), influenza vaccination should ... helping communities across Massachusetts , Connecticut ... shots through the end of the month. *Some exclusions apply ... ... is by the end of October, according to the Centers for Disease ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... , ... Global Healthcare Management’s 4th Annual Kids Fun Run brought out many ... event, sponsored by Global Healthcare Management’s CEO, Jon Letko, is aimed at getting kids ... of all ages; it is a non-competitive, non-timed event, which is all about having ...
(Date:10/13/2017)... , ... October 13, 2017 , ... “The Journey: From ... every danger possible to save lost souls in the Philippines. “The Journey: From the ... is a dedicated teacher of the Bible. She has taught all ages and currently ...
(Date:10/12/2017)... LA (PRWEB) , ... October 12, 2017 , ... Planet ... in the U.S., announced today its plans to open a flagship location in Covington, ... occupy the former Rooms To Go store next to Office Depot in the Holiday ...
(Date:10/12/2017)... ... 2017 , ... Asante, a nationally recognized health system in ... existing home health joint venture through an agreement, effective October 1, 2017, to ... home health company with Asante, delivering clinically integrated care, for the past eight ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts ... Washington, D.C., for the 49th Congress of the International Society of Paediatric Oncology ... of the Center for Cancer and Blood Disorders at Children’s National, and ...
Breaking Medicine News(10 mins):